178 related articles for article (PubMed ID: 37837357)
1. Autotaxin-lysophosphatidic acid receptor 5 axis evokes endothelial dysfunction via reactive oxygen species signaling.
Janovicz A; Majer A; Kosztelnik M; Geiszt M; Chun J; Ishii S; Tigyi GJ; Benyó Z; Ruisanchez É
Exp Biol Med (Maywood); 2023 Oct; 248(20):1887-1894. PubMed ID: 37837357
[TBL] [Abstract][Full Text] [Related]
2. Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin/lysophosphatidic acid axis.
Bai Z; Cai L; Umemoto E; Takeda A; Tohya K; Komai Y; Veeraveedu PT; Hata E; Sugiura Y; Kubo A; Suematsu M; Hayasaka H; Okudaira S; Aoki J; Tanaka T; Albers HM; Ovaa H; Miyasaka M
J Immunol; 2013 Mar; 190(5):2036-48. PubMed ID: 23365076
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute-on-Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid-Dependent Monocyte Activation.
Trovato FM; Zia R; Napoli S; Wolfer K; Huang X; Morgan PE; Husbyn H; Elgosbi M; Lucangeli M; Miquel R; Wilson I; Heaton ND; Heneghan MA; Auzinger G; Antoniades CG; Wendon JA; Patel VC; Coen M; Triantafyllou E; McPhail MJ
Hepatology; 2021 Aug; 74(2):907-925. PubMed ID: 33908067
[TBL] [Abstract][Full Text] [Related]
4. The phospholipase A2 activity of peroxiredoxin 6 modulates NADPH oxidase 2 activation via lysophosphatidic acid receptor signaling in the pulmonary endothelium and alveolar macrophages.
Vázquez-Medina JP; Dodia C; Weng L; Mesaros C; Blair IA; Feinstein SI; Chatterjee S; Fisher AB
FASEB J; 2016 Aug; 30(8):2885-98. PubMed ID: 27178323
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.
Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H
Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050
[TBL] [Abstract][Full Text] [Related]
6. The atherogenic actions of LPC on vascular smooth muscle cells and its LPA receptor mediated mechanism.
Bao L; Qi J; Wang YW; Xi Q; Tserennadmid T; Zhao PF; Qi J; Damirin A
Biochem Biophys Res Commun; 2018 Sep; 503(3):1911-1918. PubMed ID: 30064908
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H
Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636
[TBL] [Abstract][Full Text] [Related]
8. Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na
Jenkin KA; He P; Yun CC
Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G433-G442. PubMed ID: 29792531
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model.
Uranbileg B; Ito N; Kurano M; Saigusa D; Saito R; Uruno A; Kano K; Ikeda H; Yamada Y; Sumitani M; Sekiguchi M; Aoki J; Yatomi Y
Sci Rep; 2019 Nov; 9(1):16578. PubMed ID: 31719574
[TBL] [Abstract][Full Text] [Related]
10. Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine.
Nagai J; Uchida H; Matsushita Y; Yano R; Ueda M; Niwa M; Aoki J; Chun J; Ueda H
Mol Pain; 2010 Nov; 6():78. PubMed ID: 21062487
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain.
Inoue M; Ma L; Aoki J; Ueda H
J Neurochem; 2008 Dec; 107(6):1556-65. PubMed ID: 19014389
[TBL] [Abstract][Full Text] [Related]
12. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.
Kishi Y; Okudaira S; Tanaka M; Hama K; Shida D; Kitayama J; Yamori T; Aoki J; Fujimaki T; Arai H
J Biol Chem; 2006 Jun; 281(25):17492-17500. PubMed ID: 16627485
[TBL] [Abstract][Full Text] [Related]
13. Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5.
Wang M; He P; Han Y; Dong L; Yun CC
Cell Mol Gastroenterol Hepatol; 2021; 12(3):1073-1092. PubMed ID: 33975030
[TBL] [Abstract][Full Text] [Related]
14. Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Exp Mol Pathol; 2021 Feb; 118():104596. PubMed ID: 33347862
[TBL] [Abstract][Full Text] [Related]
15. Autotaxin structure-activity relationships revealed through lysophosphatidylcholine analogs.
North EJ; Osborne DA; Bridson PK; Baker DL; Parrill AL
Bioorg Med Chem; 2009 May; 17(9):3433-42. PubMed ID: 19345587
[TBL] [Abstract][Full Text] [Related]
16. Autotaxin-Lysophosphatidic Acid Pathway in Intraocular Pressure Regulation and Glaucoma Subtypes.
Honjo M; Igarashi N; Kurano M; Yatomi Y; Igarashi K; Kano K; Aoki J; Weinreb RN; Aihara M
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):693-701. PubMed ID: 29392315
[TBL] [Abstract][Full Text] [Related]
17. Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders.
Alioli C; Demesmay L; Peyruchaud O; Machuca-Gayet I
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408784
[TBL] [Abstract][Full Text] [Related]
18. Acyl chain-dependent effect of lysophosphatidylcholine on endothelium-dependent vasorelaxation.
Rao SP; Riederer M; Lechleitner M; Hermansson M; Desoye G; Hallström S; Graier WF; Frank S
PLoS One; 2013; 8(5):e65155. PubMed ID: 23741477
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype.
Plastira I; Bernhart E; Goeritzer M; DeVaney T; Reicher H; Hammer A; Lohberger B; Wintersperger A; Zucol B; Graier WF; Kratky D; Malle E; Sattler W
J Neuroinflammation; 2017 Dec; 14(1):253. PubMed ID: 29258556
[TBL] [Abstract][Full Text] [Related]
20. Oleoyl-lysophosphatidylcholine limits endothelial nitric oxide bioavailability by induction of reactive oxygen species.
Kozina A; Opresnik S; Wong MS; Hallström S; Graier WF; Malli R; Schröder K; Schmidt K; Frank S
PLoS One; 2014; 9(11):e113443. PubMed ID: 25419657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
